Maven Securities LTD F Star Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $585 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$5.41 - $6.74 $351,422 - $437,816
-64,958 Reduced 57.05%
48,901 $2.5 Million
Q2 2022

Aug 15, 2022
BUY
$2.18 - $6.39 $248,212 - $727,559
113,859 New
113,859 $713,000
Q3 2021

Nov 15, 2021
SELL
$5.2 - $8.42 $753,646 - $1.22 Million
-144,932 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$6.57 - $10.71 $952,203 - $1.55 Million
144,932 New
144,932 $1.26 Million

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email